StreetInsider.com News Articles

Form 4 Krystal Biotech, Inc. For: Jun 25 Filed by: Thomas John Charles

Fri, 26 Jun 2026 18:46:00 -0400

si-local-file:///var/storage/secattach/20260626/26700198.html

Form 4 Krystal Biotech, Inc. For: Jun 25 Filed by: Thomas John Charles

Fri, 26 Jun 2026 18:46:00 -0400

si-local-file:///var/storage/secattach/20260626/26700198.html

Krystal Biotech (KRYS) PT Raised to $395 at Evercore ISI

Fri, 26 Jun 2026 08:26:58 -0400

Evercore ISI analyst Josh Schimmer raised the price target on Krystal Biotech (NASDAQ: KRYS) to $395.00 (from $300.00) while maintaining a Outperform rating.

Form 144 Krystal Biotech, Inc. Filed by: Thomas John Charles

Thu, 25 Jun 2026 10:04:00 -0400

si-local-file:///var/storage/secattach/20260625/26689674.html

Form 144 Krystal Biotech, Inc. Filed by: Thomas John Charles

Thu, 25 Jun 2026 10:04:00 -0400

si-local-file:///var/storage/secattach/20260625/26689674.html

Krystal Biotech (KRYS) PT Raised to $403 at TD Cowen

Thu, 18 Jun 2026 07:48:19 -0400

TD Cowen analyst Ritu Baral raised the price target on Krystal Biotech (NASDAQ: KRYS) to $403.00 (from $306.00) while maintaining a Buy rating.

Krystal Biotech (KRYS) PT Raised to $361 at H.C. Wainwright

Wed, 17 Jun 2026 06:48:47 -0400

H.C. Wainwright analyst Joseph Pantginis raised the price target on Krystal Biotech (NASDAQ: KRYS) to $361.00 (from $310.00) while maintaining a Buy rating.

Form 4 Krystal Biotech, Inc. For: Jun 04 Filed by: Krishnan Suma

Fri, 05 Jun 2026 18:41:00 -0400

si-local-file:///var/storage/secattach/20260605/26612537.html

Form 4 Krystal Biotech, Inc. For: Jun 04 Filed by: Krishnan Suma

Fri, 05 Jun 2026 18:41:00 -0400

si-local-file:///var/storage/secattach/20260605/26612537.html

Form 4 Krystal Biotech, Inc. For: Jun 04 Filed by: Krishnan Krish S

Fri, 05 Jun 2026 18:39:00 -0400

si-local-file:///var/storage/secattach/20260605/26612530.html

Form 4 Krystal Biotech, Inc. For: Jun 04 Filed by: Krishnan Krish S

Fri, 05 Jun 2026 18:39:00 -0400

si-local-file:///var/storage/secattach/20260605/26612530.html

Form 144 Krystal Biotech, Inc. Filed by: Krishnan Krish S

Thu, 04 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260604/26606213.html

Form 144 Krystal Biotech, Inc. Filed by: Krishnan Krish S

Thu, 04 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260604/26606213.html

Form 144 Krystal Biotech, Inc. Filed by: Krishnan Suma

Thu, 04 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260604/26606225.html

Form 144 Krystal Biotech, Inc. Filed by: Krishnan Suma

Thu, 04 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260604/26606225.html

Form 4 Krystal Biotech, Inc. For: May 26 Filed by: Thomas John Charles

Wed, 27 May 2026 17:18:00 -0400

si-local-file:///var/storage/secattach/20260527/26559153.html

Form 4 Krystal Biotech, Inc. For: May 26 Filed by: Thomas John Charles

Wed, 27 May 2026 17:18:00 -0400

si-local-file:///var/storage/secattach/20260527/26559153.html

Form 144 Krystal Biotech, Inc. Filed by: Thomas John Charles

Tue, 26 May 2026 10:31:00 -0400

si-local-file:///var/storage/secattach/20260526/26547507.html

Form 144 Krystal Biotech, Inc. Filed by: Thomas John Charles

Tue, 26 May 2026 10:31:00 -0400

si-local-file:///var/storage/secattach/20260526/26547507.html

Corbus names Nishant Saxena as chief business officer

Thu, 21 May 2026 08:01:06 -0400

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) appointed Nishant Saxena as its first chief business officer, the company announced. Saxena previously served as chief financial officer at Jeune Aesthetics Inc., a subsidiary of Krystal Biotech Inc. (NASDAQ: KRYS).

Saxena brings over 20 years of experience in finance, strategy, capital markets, and corporate development. He spent more than 15 years at Evercore as a managing director in the healthcare group, where he advised on transactions totaling over $500 billion in aggregate value. He holds a bachelor's degree in economics and an MBA from the Wharton School at the University of Pennsylvania.

The appointment comes

Corbus names Nishant Saxena as chief business officer

Thu, 21 May 2026 08:01:06 -0400

The appointment comes

Corbus names Nishant Saxena as chief business officer

Thu, 21 May 2026 08:01:06 -0400

The appointment comes

Corbus names Nishant Saxena as chief business officer

Thu, 21 May 2026 08:01:06 -0400

The appointment comes

Form 8-K Krystal Biotech, Inc. For: May 15

Wed, 20 May 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260520/26524212.html

Form 8-K Krystal Biotech, Inc. For: May 15

Wed, 20 May 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260520/26524212.html